Clinical Trial Update: Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial comparing chemotherapy versus chemoradiotherapy for post-operative endometrial cancer patients with P53 mutation; currently not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Fudan University | Conditions: Endometrial Cancer | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING